All three testmakers cited in March 1 FDA warning letters have received the agency’s clearance to market COVID-19 diagnostics separate from those identified in the letters, including an at-home test ...
As the spread of dengue and malaria once again bedevils people in the port city, diagnostic tests and platelet treatments have become unaffordable for the public. As a result, small laboratories are ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results